The Role of Citicoline in Post-Brain Surgery Children

Authors

  • Lina Purnamasari Pediatrician at Ulin Hospital

DOI:

https://doi.org/10.55175/cdk.v51i5.1050

Keywords:

Citicoline, citicoline in children, neurological disorders, neuroprotector

Abstract

Citicoline is a drug that has many benefits as a neuroprotector. Many studies in adults show the clinical benefits of citicoline in various neurological disorders such as dementia, head trauma, stroke, Parkinson, etc. However, the effectiveness of citicoline in children has not been widely studied.

Downloads

Download data is not yet available.

References

Al Mosawi AJ. The use of citicoline in pediatric neurology and pediatric psychiatry. Austin Pediatr. 2019;6(1):1071-2.

Jasielski P, Piędel F, Piwek M, Rocka A, Petit V, Rejdak K. Application of citicoline in neurological disorders: A systematic review. Nutrients 2020;12(10): 1-20.

Iulia C, Ruxandra T, Costin LB, Liliana-Mary V. Citicoline - a neuroprotector with proven effects on glaucomatous disease. Rom J Ophthalmol. 2017 Jul-Sep;61(3):152-8.

Qureshi SS, Gupta JK and Mishra P. Citicoline: A potential breakthrough in cerebrovascular disorder. Austin J Pharmacol Ther. 2016;4(1):1-4.

Al-Mosawi AJ. A novel therapeutic approach for kernicterus (ed). Germany: LAP Lambert Academic Publishing; 2018.

Al-Mosawi AJ. New therapies for the treatment of spastic cerebral palsy. Med J Clin Trials Case Stud. 2019;3:000209.

Al-Mosawi AJ. The use of cerebrolysin and citicoline in autism and Asperger syndrome. J Bio Innov. 2019;8:99-108.

Salamah A, Mehrez M, Faheem A, El Amrousy D. Efficacy of citicoline as a neuroprotector in children with post cardiac arrest: A randomized controlled clinical trial. Eur J Pediatr. 2021;180(4):1249-55.

Secades JJ. Role of citicoline in the management of traumatic brain injury. Pharmaceuticals (Basel). 2021 Apr 26;14(5):410.

Sufianova GZ, Shapkin AG, Sufianov AA, Khlеstkina MS, Sufianov RA, Mashkin AM. Comparative evaluation of pre- and postoperative administration of citicoline: Clinical outcomes and the volume of ischemic brain damage after meningioma removal. Sechenov Med J. 2019;10(4):12-20.

Centre for Evidence-Based Medicine. Oxford centre for evidence-based medicine: Levels of evidence (March 2009) [Internet] 2022. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009.

PDQ Pediatric Treatment Editorial Board. Childhood ependymoma treatment (PDQ®): Health professional version. 2022 Aug 5. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2024. Available from: https://www.ncbi.nlm.nih.gov/books NBK65935/

Leng X, Tan X, Zhang C, Lin H, Qiu S. Magnetic resonance imaging findings of extraventricular anaplastic ependymoma: A report of 11 cases. Oncol Lett. 2016;12(3):2048-54.

Travis ZD, Sherchan P, Hayes WK, Zhang JH. Surgically-induced brain injury: Where are we now? Chinese Neurosurg J. 2019;5(1):1-11.

Trimmel H, Majdan M, Wodak A, Herzer G, Csomor D, Brazinova A. Citicoline in severe traumatic brain injury: Indications for improved outcome: A retrospective matched pair analysis from 14 Austrian trauma centers. Wien Klin Wochenschr. 2018;130(1-2):37-44.

Published

02-05-2024

How to Cite

Purnamasari, L. (2024). The Role of Citicoline in Post-Brain Surgery Children. Cermin Dunia Kedokteran, 51(5), 275–279. https://doi.org/10.55175/cdk.v51i5.1050